Acurx Pharmaceuticals, Inc.
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Nov 10, 2026 (15 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 29, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Sep 30, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $31 | 44% |
| Aug 12, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $31 | 44% |
| Mar 19, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Jan 13, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Jan 10, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Dec 10, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Nov 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Aug 12, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| May 16, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $12 | 44% |
| Mar 19, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $12 | 44% |
| Feb 28, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $14 | 44% |
| Dec 15, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $14 | 44% |
| Nov 15, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $13 | 44% |
| Sep 13, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $13 | 44% |
| Aug 15, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $13 | 44% |
| May 15, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $14 | 44% |
| Apr 11, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $14 | 44% |
| Mar 17, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $14 | 44% |
| Dec 19, 2022 | HC Wainwright & Co. | initiate | — → Buy | $14 | 44% |
| Oct 20, 2022 | Alliance Global Partners | initiate | — → Buy | $14 | 41% |
| Nov 29, 2021 | Maxim Group | initiate | — → Buy | $12 | 42% |
No cross-platform signals in the last 90 days